menu
    • menu

    Company profile for Scribe Therapeutics

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Scribe TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1150 Marina Village Pkwy, Alameda, CA 94501, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.scribetx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/scribe-therapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scribe Presents STX-1150 Epigenetic LDL-C Silencing Data
    Scribe Presents STX-1150 Epigenetic LDL-C Silencing Data

    28 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260528472123/en/Scribe-Therapeutics-Presents-Late-Breaking-Preclinical-Data-Supporting-STX-1150-a-Clinical-Stage-Epigenetic-Silencing-Therapy-Designed-to-Achieve-Years-of-LDL-C-Lowering-After-a-Single-Dose

    BUSINESSWIRE
    28 May 2026
    Share Share
    Scribe Therapeutics Clears Regulatory Hurdle for STX-1150 Trial
    Scribe Therapeutics Clears Regulatory Hurdle for STX-1150 Trial

    21 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260521228404/en/Scribe-Therapeutics-Achieves-Regulatory-Clearance-to-Initiate-First-in-Human-Clinical-Study-of-STX-1150-for-LDL-C-Reduction

    BUSINESSWIRE
    21 May 2026
    Share Share
    Scribe Therapeutics Presents Enhanced CRISPR Data at ASGCT 2026
    Scribe Therapeutics Presents Enhanced CRISPR Data at ASGCT 2026

    18 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-18/scribe-therapeutics-reports-preclinical-data-at-asgct-2026-demonstrating-enhanced-potency-and-specif

    PHARMIWEB
    18 May 2026
    Share Share
    Scribe Therapeutics to Show CRISPR and Cardio Data at ASGCT
    Scribe Therapeutics to Show CRISPR and Cardio Data at ASGCT

    30 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260430225629/en/Scribe-Therapeutics-to-Highlight-Engineered-CRISPR-Platform-Advances-and-Lead-Cardiometabolic-Pipeline-at-ASGCT-and-EAS-Congress-2026

    BUSINESSWIRE
    30 Apr 2026
    Share Share
    Scribe Therapeutics Eyes Mid-2026 Debut for STX-1150
    Scribe Therapeutics Eyes Mid-2026 Debut for STX-1150

    20 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260120569064/en/Scribe-Therapeutics-Projected-to-Enter-the-Clinic-in-Mid-2026-with-STX-1150-a-PCSK9-targeting-CRISPR-Epigenetic-Silencing-Therapy-for-Durable-LDL-C-Reduction

    BUSINESSWIRE
    20 Jan 2026
    Share Share
    Scribe Therapeutics Presents at 44th JPM Healthcare Conference
    Scribe Therapeutics Presents at 44th JPM Healthcare Conference

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215998118/en/Scribe-Therapeutics-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    15 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search